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Summary.-Antioxidants were found to inhibit the mixed-function oxidation of
benzo(a)pyrene in several tissues of untreated and 3-methylcholanthrene-pretreated
rats. The enzyme systems in the liver, kidney and stomach were much more sus-
ceptible to inhibition than those in the lung, adrenal, colon and small intestine. In all
tissues except the stomach it was found that 3-methylcholanthrene pretreatment led
to a decrease in inhibition of benzo(a)pyrene 3-hydroxylase activity. It is suggested
that antioxidants exert their protective effect against cancer by inhibiting the forma-
tion of carcinogenic metabolites. Of the various steroids tested, only 17,B-oestradiol
and oestrone were significantly inhibitory in most tissues. Cholesterol was found
to increase benzo(a)pyrene 3-hydroxylase activity in the gastrointestinal tract.
NUMEROUS STUDIES have indicated the
importance of environmental factors in
the onset of chemical carcinogenesis
(Haenszel & Kurihara, 1968; Armstrong
& Doll, 1975; Wynder, 1976). There is
already strong evidence that diet is a
major factor in determining the incidence
of many cancers (Carroll & Khor, 1975;
Miller & Miller, 1976; Wynder, 1976). A
drop in the incidence of stomach cancer
in the U.S.A. has been attributed by
Wattenberg (1975) at least partially to the
increased consumption of antioxidants.
These are commonly added to human and
animal food as preservatives for poly-
unsaturated lipids and other ingredients
subject to spoilage by oxidation. These
compounds produce a variety of physio-
logical effects in animals, and their role
as protective agents against the deleterious
effects of various carcinogens is becoming
increasingly apparent. Particularly well
examined are the effects of the phenolic
antioxidants butylated hydroxytoluene
(BHT) and butylated hydroxyanisole
(BHA) which are extensively used in food,
and ofethoxyquin, which is widely used in
commercial animal diets. BHT and BHA
when added to commercial diets containing
the carcinogens benzo(a)pyrene (BP) and
7,12 - dimethylbenzanthracine (DMBA)
showed pronounced suppression of neo-
plasia ofthe forestomach in mice (Watten-
berg, 1972a; Cumming & Walton, 1973;
Wattenberg, 1973). In vivo feeding of the
antioxidants ethoxyquin and disulfiram
have also been shown to protect mice and
rats from neoplasia produced by a variety
of carcinogens including BP, DMBA, and
diethylnitrosamine (Wattenberg, 1972a,
1972b, 1974). The actual mechanism by
which the various antioxidants inhibit
chemical carcinogenesis has not been
determined. Female mice fed BHA showed
alterations in the metabolism of BP
(Speier & Wattenberg, 1975). These in-
vestigations also showed that incubation
of BP and calf thymus DNA with liver
microsomal fractions from BHA-fed mice
showed about one-half the binding of BP
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metabolites to DNA as in the controls.
BP is a carcinogen that reqtuires metabolic
activation in order to be an effective
initiator of neoplasia (Miller & Miller,
1974; Sims & Gurover, 1974). The enzyme
system responsible for this activation con-
sists of a haemoprotein cytochrome P450,
a flavoprotein NADPH-cytochrome P450
reductase and phospholipid (Lu et al.,
1969). This enzyme systenm resides mainly
in the microsomal fractions of several
tissues (Wattenberg & Leong, 1962;
Zampaglione & Mannering, 1973; Chhabra
& Fouts, 1974) but has also been shown to
be active in the nuclear fraction of rat
liver (Khandwala & Kasper, 1973; Rogan
et al., 1976). In vitro studies have shown
that BP is metabolized to a complex array
of metabolites which include arene oxides,
phenols, quinones and dihydrodiols
(Holder et al., 1974; kSelkirk et al., 1974;
Sims & Grover, 1974). Recentlv Lam &
Wattenberg (1977) have shown that
microsomes prepared from livers of BHA-
fed mice showed a significant decrease in
the amount of BP-4,5-epoxide and an
increase in 3-hydroxy BP, compared with
microsomes from control mice. Epoxides
are believed to be the metabolites most
probably responsible for chemical carcino-
genicity of polycylcic hydrocarbons
(Heidelberger, 1973; Jerina & Daly, 1974;
Sims & Grover, 1974) and Lam & Watten-
berg (1977) propose that a decrease in the
amount of epoxides formed from micro-
somes of BHA-fed mice may explain the
protection afforded bv this antioxidant
against carcinogenesis.
In a past communication (Rahimtula
et al., 1977) we showed that various anti-
oxidants inhibited the 3-hydroxylation of
BP with microsomes prepared from livers
of control rats. In this report we have
examined the response of various tissue
homogenates prepared from control and
3-methylcholanthrene (MC) treated rats
to a variety of antioxidants and sterols.
Our results indicate that in general the
enzyme system from liver, kidney and
stomach is inhibited to a much greater
extent by antioxidants than that from the
lungs, small intestine, adrenals and colon.
Furthermore, MC induction makes all the
tissues except stomach more resistant to
inhibition by antioxidants. Of the various
sterols tested, 17/-oestradiol was the most
effective in inhibiting BP 3-hydroxylation
in all tissues.
MATERIALS AND METHODS
NADPH, BP, cholesterol, androstenedione.
reduced glutathione, cytochrome c, propyl
gallate, BHA and BHT were purchased from
the Sigma Chemical Co. (St Louis, MO,
U.S.A.). Ethoxyquin was a gift from the
Monsanto Chemical Co. (St Louis, MO,
U.S.A.). Cortisol, cortisone, testosterone,
oestrone and 17/-oestradiol wrere kindlv
provided by Dr James Orr, Faculty of
Medicine, Memorial University of New-
foundland (Canada). All other chemicals and
reagents used were of the highest grade com-
mercially available.
Male Sprague-Dawley rats weighing about
200 g each were used in all the experiments.
Aryl hydrocarbon hydroxylase wAas induced
by 2 i.p. injections of MC (8 mg dissolved in
0-5 ml corn oil) 24 h apart. The rats were
killed 24-30 h after the second injection. The
various tissues from 3-4 rats (control or MC)
were pooled and processed. The liver, lungs,
kidneys and adrenals from control and MC-
treated rats were removed and placed in
separate beakers containing cold 0-90 saline.
The entire intestine w%Na,s removed and wAashed
2-3 times by pushing ice-cold saline with a
syringe through the lumen until the intestines
were free of exereta. The stomach was also
removed, slit open and washed with saline
until free of food particles. Liver and kidneys
were chopped into pieces and homogenized
in a Potter-Elvehjem homogenizer with 3-4
volumes of cold 0dIM Tris HCI buffer (pH
7 4). The lungs, small intestine, colon and
stomach were homogenized in an ice-cold
Waring blender for 1 min with 4-5 volumes
of 0-IM Tris HCl buffer (pH 7.4) followed by
filtration through cheesecloth. The resulting
homogenates were centrifuged at 10,000 ,
for 15 min. The 10,000 q supernatant from
each of the tissues wNas divided into suitable
portions and frozen at -70°C. All tissues were
investigated within 2 weeks offreezing. In all
cases actual analysis of control and MC-
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induced tissues was done on the saine day.
Protein was determined by the method of
Lowry et al. BP 3-hydroxylase was measured
fluorimetrically as described by Nebert &
Gelboin (1968). The incubation mixture con-
tained in a final volume of 1-0 ml: 100 Htmol of
Tris-HCl buffer (pH 7 5), 1 Htmol NADPH,
10,000 g supernatant (0-2-1-0 mg protein)
and the appropriate agent when added
(dissolved in wNater or acetone and added at
the desired concentration in a volume of 10 pu
or less). The antioxidants, steroids, etc.. wNere
added first to the 10,000 g supernatant in
buffer and allowN-ed a few minutes for binding
to occur before addition ofother components.
The reaction was started by adding 70 nmol
of BP in 30 ytl of acetone and the incubation
continued for 10 min at 37°C before termina-
tion with 4-25 ml of acetone: hexane (1: 3).
The mixture was vortexed for 1 min and
centrifuged for 2 min and 2 5 ml ofthe organic
layer was extracted with 2-5 ml of IN NaOH.
After centrifugation for 2 min the concentra-
tion ofthe extracted, hydroxylated BP in the
alkali phase was determined spectrophoto-
fluorometrically, with excitation at 396 nm
and fluorescence emissioni at 522 nm. A 3-
hydroxy BP standard solution was used to
check the sensitivity of the assay procedure.
RESULTS
Effect of MC pretreatment on BP
hydroxylation in various tissues is showAn
in Table 1. Pretreatment with MC showed
differences in the degree of induction in
various tissuies, except adlrenals which
showed a drop in specific activity. The
liver and lungs showed a 5 8-fold and 5 2-
fold induction respectively on MC pre-
treatment and this agrees well with the
results obtained by Lake et al. (1973). The
most dramatic effect was observed on the
kidney, small intestine and colon where
the induction was 36-, 48-, and 63-fold
respectively. Lake et al. (1973) found a
20-fold increase in BP 3-hydroxylation in
both the kidney microsomes and intestinal
mutcosal cell homogenates. Similarly
Stohs et al. (1976) found a maximtum of
30-fold induction in 3-hydroxy BP forma-
tion from intestine mucosal-microsomes
prepared from MC-treated rats. In con-
trast to the small initestine and colon, the
TABLE I. Effect of MC administration on
BP 3-hydroxylase activity in some rat
tissates*
Tissue
Liver
Kidey
Adrenals
Lungs
Stomach
Coloni
Small intestine
3-Hydroxy BP forme(d
(pmol/min/mg)
:3-AIC-
Unitreate(d treate(1 Fol(d
Irats rats induction
90±3-2 520±11 5d0
2 71 04 98±4 35 6
21*9±2 2 18-8±2 0-86
07 01 :37±04 5-2
07-01l 57±04 85
0-25±0-05 15-8± 1-7 63
1-7-0-2 82±:3- 48
Assavs weie carried out in triplicate as (lescribed
ini TMethods. The inctubation mixture containe(d in
1 ml: 100 ,umol Tris HCI (pH 7-5 at 37°C), 80 nmol
B(a)P andt 0-2 mg piotein (liver) oIr 0-3 mg protein
(adrenals) or 0-5 mg proteini (kidney) or 1 mg
protein (lutntgs, coloni, stomach, small initestine).
Reaction was starte(t by the a(ldition of 1 /tmol
NADPH and(t terminate(1 aftei 10 min at 37 C.
stomach showed only a modest induction
of 8-5-fold, and its specific activity was
also quite low after induction. To date we
are unaware of any studies that have
exan-iined differences in BP 3-hydroxyla-
tion in the colon, small intestine and
stomach of control and MC-induced
animals.
Tables II and III list the effects of
various antioxidants and other agents in
BP 3-hydroxyvlation. Of the various anti-
oxidants tested quercetin was found to be
the most effective, and at a concentration
of 125 [km caused very significant inhibition
in all the tissues. Santoquin, propylgallate
and BHA were intermediate in effective-
ness, whilst BHT was the least effective.
Ascorbate and glutathione are two natur-
ally occurring reducing agents with anti-
oxdant properties. Their levels can be
quite significant in some tissues, e.g. the
levels ofglutathione are .5-l 0 mm in the
kidney and adrenals. Glutathione caused
a significant inhibition of 3-hydroxy BP
formation in the adrenals (Table II) and
stomach (Table III), while its effect on the
kidney, colon and small intestine was
marginal (30°, inhibition). Ascorbate at a
concentration of 5 mM caused a partial
inhibitioni only in the adrenals and kidney,
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TABLE II.-Effect of some antioxidants and other agents on BP 3-hydroxylase activity in
liver, lungs, adrenals and kidneys of rat*
Addition to the system
No addition
BHA
BHT
Propyl gallate
Quercetin
Santoquin
GSH
Ascorbate
Cytochrome c
Menadione
25 /lM
125 /IM
25 .M
125 /M
25 ,M
125 ,4M
25 pM
125 1tM
25 pM
125 /tM
5 mM
5 mM
10 pM
50 /uM
Liver Lungs Adrenals
Control 3-MC Control 3-MC Control 3-MC
100±4t 100+5 100±13 100+11 100±10 100±1
70±4 98±3 210±20 109±11 110±6 97±7
35±2 82±5 202±15 120±13 113±13 98±14 85±4 97±6 140±8 64±5 102±5 94±9
55±3 90±4 165±10 102±6 100±6 102±7
75±5 93±5 104±8 102±4 100±8 97±8
45±2 84±3 44±5 96±5 100±6 103±6
53±3 62±6 85±7 57±6 104±7 94±5
13±1 22±2 46±6 30±4 65±6 59±4
47±3 93±7 73± 6 80±6 104±10 94±7
22±2 80±4 14±2 84±9 83±8 78±9
95±3 93±5 160±11 84±3 52±6 50±5
93±6 95±6 107±9 89±7 78±4 75±6
20±2 83±5 11±1 4±2 0 0
47±4 82±7 102±4 84±3 6±2 4±3
Control
2 100±17
75±6
0 55±5
73±6
68±8
55±4
41±5
41±3
20±2
50±6
41±3
68±4
86±7
2±2
55±4
*Assays were carried out in triplicate as described in Methods section and in footnote to Table I. All
activities are reported relative to "No addition" as 100%.
tMean±s.d.
TABLE III.-Effect of some antioxidants and other agents on BP 3-hydroxylase activity in
the colon, stomach and small intestine of rat
Stomach
t A
Addition to the system
No addition
BHA
BHT
Propyl gallate
Quercetin
Santoquin
GSH
Ascorbate
Cytochome c
Menadione
25 /LM
125 pM
25 ,IM
125 uM
25 uM
125 tM
25 pM
125 tM
25 /Lm
125 uM
5 mM
5 mM
10 ,uM
50 ,im
Control
100± 10
61±5
22±3
50±6
33±4
2544
17±3
78±9
61±4
28±5
0
44±5
300+50
0
600 ± 50
3-MC
100± 9
19±4
19±5
51±7
26±6
26±4
±
7±3
14±4
14±3
28± 2
7±3
47±4
125 ±11
0
200± 15
whilst it enhanced 3-hydroxy BP forma-
tion in the stomach and small intestine.
Cytochrome c and menadione (Vit. K3) are
two agents that can accept electrons from
reduced hepatic NADPH cytochrome P450
reductase (Rahimtula & O'Brien, 1977),
thereby interrupting the flow of electrons
to cytochrome P450. Cytochrome c was
particularly effective and was able to
abolish 3-hydroxy BP formation in the
adrenals, lung, stomach and kidney,
while significantly inhibiting its formation
in the liver, colon and small intestine.
Colon Small intestine
Control 3-MC Control 3-MC
100±12 100±8 100±13 100±7
80±10 100±3 100±6 97±3
84±9 105±4 100±4 94±7
92±9 100±10 100±9 96±4
92±11 136±11 84±11 94±6
60±7 79±6 69±6 98±9
80±6 110±8 81±8 110±4
60±5 136±14 69±3 100±6
28±5 79±6 22±7 60±7
96±11 71±9 78±4 82±8
60±3 93±5 78±9 78±6
80±12 71±6 75±8 72±9
112±15 86±8 138±8 103±8
48±4 50±7 63±7 84±8
180±11 107±7 141±15 110±9
Menadione was not quite as effective as
cytochrome c and caused a 95% inhibition
only in the adrenals, while actually
stimulating 3-hydroxy BP formation in
the stomach, colon and small intestine. Its
inhibitory effect on the liver and kidney
was partial.
The effect of several sterols on BP 3-
hydroxylation in the various tissues is
seen in Tables IV and V. Of the 8 sterols
tested only 17-oestradiol caused a
marked inhibition in all tissues except
adrenals. DiGiovanni et al. (1977) also
Kidney
3-MC
100±4
100±3
106± 7
102±8
99±4
100±9
100±11
68±5
25±4
98±7
90±9
69±6
81±5
21±3
80±4
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TABLE IV.-Effect of some antioxidants and other agents on BP 3-hydroxylase activity in
the liver, lungs, adrenals and kidney of rat
Addition to the system
No addition
Cholesterol 250 ,tM
Cortisol 250 /tM
Cortisone 250 ztM
Androstenedione 250 ztM
Testosterone 250 ,iM
Prednisone 250 /tm
Oestrone 250 izM
17fl-Oestradiol 250 pM
Liver Lungs Adrenals Kidney
Control 3-MC Control 3-MC Control 3-MC Control 3-MC
100±4 100±5 100±13 100+11 100±10 100+12 100±17 100+4
100±10 91±6 78±8 100±9 94±6 85±9 100±9 88±8
82±11 94±10 85±9 105±4 92±9 90±9 82±3 82±5
79±10 94±4 61±7 89±7 83±8 88±4 88±11 91±3
68±10 72±8 85±4 105±3 75±11 80±9 105±12 79±8
47±4 59±10 91±3 98±9 72±3 85±7 67±10 71±9
74±7 91±6 88±6 103±6 92±6 93±11 73±8 56±7
74±8 84±7 18±4 57±7 89±8 95±7 73±8 56±7
44±5 66±8 24±8 42±11 75±9 93±6 8±4 33±6
TABLE V.-Effect of some steroids on BP 3-hydroxylase activity in the stomach, colon
and small intestine of the rat
Addition to the system
No addition
Cholesterol 250 tM
Cortisol 250 uM
Cortisone 250 ,IM
Androstenedione 250 4M
Testosterone 250 tM
Prednisone 250 tM
Oestrone 250 ,IM
17f-Oestradiol 250 ,tM
Stomach
Control 3-MC
100±10 100±9
109±12 350+50
98±15 113±19
95±9 145±17
112±13 55±11
105±11 55±9
93±14 83±7
157±25 31±7
69±15 0
Colon
Control 3-MC
100±12 100±8
135±15 200±30
107±17 90±6
100±4 90±9
93±11 85±11
89±9 80±6
107±7 102±11
68±11 40±3
67±6 5±3
Small intestine
Control 3-MC
100±13 100±7
104±4 135±15
104±12 119±20
96±11 123±11
75±11 132±4
61±10 87±11
57±6 119±8
86±4 81±7
43±9 32±7
showed that 173-oestradiol was a potent
inhibitor of DMBA metabolism in mouse
epidermal homogenates. Oestrone showed
marked inhibition in the lungs, kidney and
colon, whilst testosterone was more effec-
tive in the liver and kidney. The other
sterols such as cholesterol, cortisone and
prednisone did not cause significant in-
hibition. However, cholesterol caused a
marked stimulation in BP hydroxylation
in the stomach, colon and small intes-
tine.
DISCUSSION
Numerous studies have shown that
several antioxidants can reduce the inci-
dence of neoplasia in animals at various
sites (Cumming & Walton, 1973; Watten-
berg, 1972a, 1972b, 1973, 1974; Chan &
Black, 1978). In this paper we have
examined the in vitro effect ofseveral anti-
oxidants, steroids and other agents on BP
3-hydroxylation. The results obtained
suggest possible explanations for some of
the events occurring in chemical carcino-
genesis. It is interesting that different
fractions ofthe gastrointestinal tract show
different basal levels of activity as well as
different inducibility. We are now in the
process of assessing the differences in
substrate specificities of these tissues. In
a previous communication we have ex-
amined the effect of some antioxidants on
BP 3-hydroxylation in control rat liver
microsomes (Rahimtula et al., 1977). How-
ever, a comparison ofBP hydroxylation in
the liver of control and MC-treated
animals shows that antioxidants inhibit
the control homogenate system much
more effectively than the MC homogenate
system (Table II). This is probably due to
the fact that the cytochrome P448 induced
by MC is much more specific and will not
bind antioxidants well enough to cause a
significant inhibition. Also, since cyto-
chrome c and menadione are both more
effective in inhibiting BP 3-hydroxylation
in the control liver than in the induced
liver (Table II), it suggests that the flavo-
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protein is more tightly coupled to cyto-
chrome PA48 in the induced liver than to
cytochrome P450 in the normal liver.
In vitro inhibition of BP hydroxylase of
rat liver microsomes by BHA contrasts
with the result obtained by Lam &
Wattenberg (1977), who demonstrated
that mice fed BHA actually showed an in-
crease of 3-hydroxy BP formation. Slaga
& Bracken (1977) found that BHA and
BHT did not induce mouse epidermal BP
hydroxylasse or havve an effect when
added directly to the in vitro mouse
epidermal BP hydroxylase assay. How-
ever, these authors fou-nd that both BHA
and BHT were effective inhibitors of
DMBA tumorigenesis. Shilb & [ill (1977)
have recently shown that lung microsomes
from untreated mice show two binding
sites (Kms) for BP with the high type pre-
dominating. On treatment with benzo(a)
anthracene the low Km type is induced
selectively. Furthermore, only the activity
associated with the high Km is inhibited
by BHT and retinol.
All the antioxidants caused the most
significant inhibition in BP hydroxylation
in the stomach, with both control rats and
after MC induction. This may agree well
with XVattenberg's suggestion that an in-
creased intake of antioxidants (Watten-
berg, 1972a; Wattenberg et al., 1976) is
responsible for a drop in stomach cancers
in the U.S.A. Studies by Wynder & Reddy
(1975) and Wynder (1 976) have shown that
there is a positive association between
the intake of dietary fat and/or choles-
terol and the risk of cancer of the
colon. Wynder & Reddy (1975) have
shown that patients with cancer of the
colon have higher amounts of anaerobic
bacteria, total bile acids and cholesterol
metabolites as well as 7xz-hydroxylase
activity in the faeces.
It has recently been shown that feeding
BHA or santoquin to mice and rats leads
to a substantial increase in hepatic
glutathione-S-transferase activity (Benson
et al., 1978) and epoxide-hydrase activity
(Cha et al., 1978). Thus enzymes are
responsible for inactivating epoxides con-
sidered to be the proximate or ultimate
carcinogens. Our findings, showing a direct
inhibition of BP metabolism by anti-
oxidants, may be yet another way by
which these agents inhibit carcinogenesis.
Similarly, Hill (1974) has shown that
patients with cancer of the colon have
higher levels of Clostridia and bile-acid
metabolites than the controls. The possi-
bility exists that some of these changes
may give rise to cancer of the colon.
Wynder (1 ]976) has suggested that perhaps
the in vivo formation of an alkylating
cholesterol derivative and/or cholesterol
epoxide may be the ubiquitous initiating
carcinogen to the mucosa of the colon as
well as other tissues. Our results indicating
increased BP metabolism in the stomach
and colon in the presence of cholesterol
(Table V) may offer yet another alterna-
tive.
Recently, Rogan et al. (1978) reported
that in rat liver nuclei the major route by
which BP binds to DNA is the 6-position.
They propose that BP is activated via a
one-electron oxidation step to yield the
BP radical cation which then alkylates
DNA. Antioxidants are known to be par-
ticularly effective in preventing the free
radical or 1-electron oxidation of various
polyunsaturated lipids and other corn-
pounds. In this context they would be
more effective in quenching the radical
cation (Sullivan et al., 1978) although the
importance of the 6-position activation
of BP is questioned by some (King et al.,
1976). However, an epoxide rather than a
radical cation may be the intermediate
(Yang et al., 1977).
The presence of a rapidly inducible BP
hydroxylase (Wattenberg & Leong, 1965)
in the gastrointestinal tract, the skin and
lungs suggests that these tissues act as
portals of entry into the body and also
metabolize noxious agents. The same
tissues from starved rats or rats fed a
highly purified diet have no activity
(Wattenberg, 1971). It thus appears that
BP hydroxylase is not normally present in
these tissues and that its appearance only
coincides with exposure to exogenous
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inducing agents. The presence ofinducible
activity in the liver may be considered as a
secondary defence mechanism.
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